Literature DB >> 11706962

Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study.

M A Martín1, J C Rubio, J Buchbinder, R Fernández-Hojas, P del Hoyo, S Teijeira, J Gámez, C Navarro, J M Fernández, A Cabello, Y Campos, C Cervera, J M Culebras, A L Andreu, R Fletterick, J Arenas.   

Abstract

We report on 54 Spanish patients with McArdle's disease from 40 unrelated families. Molecular analysis revealed that the most common R49X mutation was present in 70% of patients and 55% of alleles. The G204S mutation was less frequent and found in 14.8% of patients and 9% of mutant alleles. The W797R mutation was observed in 16.5% of patients, accounting for 13.7% of mutant alleles. Moreover, 78% of mutant alleles among Spanish patients can be identified by using polymerase chain reaction-restriction fragment length polymorphism analysis for the R49X, G204S, and W797R mutations, which makes noninvasive diagnosis possible through molecular genetic analysis of blood DNA. Six novel mutations were found. Three were missense mutations, E348K, R601W, and A703V; two nonsense mutations, E124X and Q754X; and one single base pair deletion, 533 delA. No clear genotype-phenotype correlation emerges from our study. Most of the mutations of uncharged and solvent inaccessible residues and the truncations must disrupt the basic structure of the protein. The mutations of charged residues would be expected to interfere with internal hydrogen bonding networks, introducing severe incompatible partnering that is caused by poor packing or electrostatic repulsions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706962

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  19 in total

Review 1.  Molecular genetics of McArdle's disease.

Authors:  G Nogales-Gadea; J Arenas; A L Andreu
Journal:  Curr Neurol Neurosci Rep       Date:  2007-01       Impact factor: 5.081

Review 2.  McArdle disease: a unique study model in sports medicine.

Authors:  Alfredo Santalla; Gisela Nogales-Gadea; Niels Ørtenblad; Astrid Brull; Noemi de Luna; Tomàs Pinós; Alejandro Lucia
Journal:  Sports Med       Date:  2014-11       Impact factor: 11.136

3.  Clinical and molecular characterization of McArdle's disease in Brazilian patients.

Authors:  Juliana Gurgel-Giannetti; Gisela Nogales-Gadea; Hélio van der Linden; Túlio Marcus Ribeiro Bellard; Geraldo Brasileiro Filho; Alexandre Varella Giannetti; Eralda Luiza de Castro Concentino; Mariz Vainzof
Journal:  Neuromolecular Med       Date:  2013-05-08       Impact factor: 3.843

4.  Mobilisation of mesenchymal cells into blood in response to skeletal muscle injury.

Authors:  M Ramírez; A Lucia; F Gómez-Gallego; J Esteve-Lanao; A Pérez-Martínez; C Foster; A L Andreu; M A Martin; L Madero; J Arenas; J García-Castro
Journal:  Br J Sports Med       Date:  2006-06-28       Impact factor: 13.800

5.  Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations.

Authors:  M Deschauer; A Morgenroth; P R Joshi; D Gläser; P F Chinnery; J Aasly; H Schreiber; M Knape; S Zierz; M Vorgerd
Journal:  J Neurol       Date:  2007-04-03       Impact factor: 4.849

6.  Can patients with McArdle's disease run?

Authors:  M Pérez; M Moran; C Cardona; J L Maté-Muñoz; J C Rubio; A L Andreu; M A Martin; J Arenas; A Lucia
Journal:  Br J Sports Med       Date:  2006-09-25       Impact factor: 13.800

7.  Inactivation of rabbit muscle glycogen phosphorylase b by peroxynitrite revisited: does the nitration of Tyr613 in the allosteric inhibition site control enzymatic function?

Authors:  Victor S Sharov; Nadezhda A Galeva; Elena S Dremina; Todd D Williams; Christian Schöneich
Journal:  Arch Biochem Biophys       Date:  2008-12-27       Impact factor: 4.013

Review 8.  McArdle disease: molecular genetic update.

Authors:  A L Andreu; G Nogales-Gadea; D Cassandrini; J Arenas; C Bruno
Journal:  Acta Myol       Date:  2007-07

9.  High frequency of missense mutations in glycogen storage disease type VI.

Authors:  N J Beauchamp; J Taybert; M P Champion; V Layet; P Heinz-Erian; A Dalton; M S Tanner; E Pronicka; M J Sharrard
Journal:  J Inherit Metab Dis       Date:  2007-08-21       Impact factor: 4.982

10.  Myophosphorylase (PYGM) mutations determined by next generation sequencing in a cohort from Turkey with McArdle disease.

Authors:  Güldal Inal-Gültekin; Bahar Toptaş-Hekimoğlu; Zeliha Görmez; Özlem Gelişin; Hacer Durmuş; Bekir Ergüner; Hüseyin Demirci; Mahmut Ş Sağıroğlu; Yeşim Parman; Feza Deymeer; Hülya Yılmaz-Aydoğan; Sadrettin Pençe; Can Ebru Bekircan-Kurt; Ersin Tan; Sevim Erdem-Özdamar; Duran Üstek; Urs Giger; Oğuz Öztürk; Piraye Serdaroğlu-Oflazer
Journal:  Neuromuscul Disord       Date:  2017-06-16       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.